Leiden researchers, led by Sebastian Pomplun, have developed a new method to screen hundreds of thousands of molecules for ...

You can always be judged by your scars. This is the idea that sums up one of the new breakthroughs in basic and biomedical research published today in the journal Science, an achievement of the ...

Tired without answers? Years‑long limbo may be nearing its end as scientists spotlight measurable clues behind relentless ...

Jian Carrot-Zhang is in the Computational Oncology Program, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York City, New York 10065, USA, and in the ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

Elevara Medicines secured $70 million in Series A funding to advance ELV001's Phase II trial for rheumatoid arthritis and explore other chronic inflammatory conditions. Pharma investments surge as ...

Merck, a leading science and technology company, has entered into a partnership with Promega Corporation, a global life science solutions and service leader based in Madison, Wisconsin in the US, to ...

Discusses 2-Year Phase II Data and AI Immunology Platform in High-Risk Melanoma October 22, 2025 10:30 AM EDTCompany ...

We could see a mass extinction event, an existential threat to multicellular life as we know it. Effective biocontainment, the researchers argue, would be incredibly difficult. If you have the time, ...

Having made it mostly in one piece to the age of 60, I was slightly fearful at having my genetic health put under the ...

Weissman was one of 77 signatories, all Nobel Prize winners, who sent an open letter on Dec. 9, 2024 to the U.S. Senate ...